DL-erythro-Dihydrosphingosine is a sphingosine-based PKC inhibitor. DL-erythro-Dihydrosphingosine directly inhibits the enzymatic activity of PLA2. DL-erythro-Dihydrosphingosine inhibits the activity of Bcl-2 protein involved in apoptosis. DL-erythro-Dihydrosphingosine inhibits the activity of matrix metalloproteinases (MMPs). DL-erythro-Dihydrosphingosine is applicable for research on cancer and inflammatory diseases[1][2].
Molecular Weight:
301.52
Purity:
98
CAS Number:
[3102-56-5]
Formula:
C18H39NO2
Target:
Apoptosis,Bcl-2 Family,MMP,Phospholipase,PKC
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted